NO933819L - Analysesystemer for neurotrofinaktivitet - Google Patents

Analysesystemer for neurotrofinaktivitet

Info

Publication number
NO933819L
NO933819L NO933819A NO933819A NO933819L NO 933819 L NO933819 L NO 933819L NO 933819 A NO933819 A NO 933819A NO 933819 A NO933819 A NO 933819A NO 933819 L NO933819 L NO 933819L
Authority
NO
Norway
Prior art keywords
assay systems
neurotrophin
activity assay
bdnf
neurotrophin activity
Prior art date
Application number
NO933819A
Other languages
English (en)
Norwegian (no)
Other versions
NO933819D0 (no
Inventor
Stephen P Squinto
David Glass
Thomas H Aldrich
Peter Distephano
Trevor Stitt
Mark E Furth
George D Yancopoulos
Peter C Maison-Pierre
Piotr Masiakowski
Nancy Ip
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of NO933819D0 publication Critical patent/NO933819D0/no
Publication of NO933819L publication Critical patent/NO933819L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO933819A 1991-04-23 1993-10-22 Analysesystemer for neurotrofinaktivitet NO933819L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69019991A 1991-04-23 1991-04-23
US73655991A 1991-07-26 1991-07-26
PCT/US1992/003376 WO1992018149A1 (fr) 1991-04-23 1992-04-23 Systemes d'analyse permettant de detecter l'activite de la neurotrophine

Publications (2)

Publication Number Publication Date
NO933819D0 NO933819D0 (no) 1993-10-22
NO933819L true NO933819L (no) 1993-12-20

Family

ID=27104557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933819A NO933819L (no) 1991-04-23 1993-10-22 Analysesystemer for neurotrofinaktivitet

Country Status (18)

Country Link
EP (2) EP0589961B1 (fr)
JP (1) JPH06509413A (fr)
AT (2) ATE214733T1 (fr)
AU (1) AU676664B2 (fr)
CA (1) CA2109100A1 (fr)
CZ (1) CZ223793A3 (fr)
DE (2) DE69233649D1 (fr)
DK (1) DK0589961T3 (fr)
ES (1) ES2170056T3 (fr)
FI (1) FI934701L (fr)
HU (1) HUT66051A (fr)
IE (1) IE921316A1 (fr)
IL (1) IL101661A (fr)
NO (1) NO933819L (fr)
NZ (1) NZ242468A (fr)
PT (1) PT100423A (fr)
SK (1) SK116593A3 (fr)
WO (1) WO1992018149A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109598A1 (fr) * 1991-05-21 1992-11-26 Finn Hallbook Methodes therapeutiques et diagnostiques basees sur l'expression de la neurotrophine 4
WO1993025684A1 (fr) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Procedes therapeutique et diagnostique bases sur l'expression de la neurotrophine-4
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−3遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5625121A (en) * 1993-09-02 1997-04-29 Bristol-Myers Squibb Company Mice deficient in nerve growth factor receptors encoded by trkB
US5753225A (en) 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
EP0939829B1 (fr) * 1996-03-28 2008-08-20 Trustees Of Boston University Techniques de modulation de la synthese de la melanine
WO1997037228A1 (fr) * 1996-03-29 1997-10-09 The Trustees Of Boston University Procedes pour diagnostiquer et traiter la maladie d'alzheimer
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
EP2789630A1 (fr) 2013-04-09 2014-10-15 EngMab AG Anticorps bispécifiques contre le CD3e et ROR1
EP3204415B1 (fr) 2014-10-09 2020-06-17 EngMab Sàrl Anticorps bispécifiques contre cd3epsilon et ror1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US5231001A (en) * 1991-03-14 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
CA2062377A1 (fr) * 1991-03-21 1992-09-22 Mariano Barbacid Methode de detection de substances neuroactives
US5843749A (en) * 1991-07-26 1998-12-01 Regeneron Pharmaceuticals, Inc. Ehk and Ror tyrosine kinases

Also Published As

Publication number Publication date
NO933819D0 (no) 1993-10-22
JPH06509413A (ja) 1994-10-20
EP1001024B1 (fr) 2006-08-16
FI934701A7 (fi) 1993-12-22
IL101661A (en) 1998-02-08
ATE336576T1 (de) 2006-09-15
ES2170056T3 (es) 2002-08-01
FI934701L (fi) 1993-12-22
ATE214733T1 (de) 2002-04-15
EP1001024A3 (fr) 2004-02-18
IL101661A0 (en) 1992-12-30
IE921316A1 (en) 1992-11-04
DK0589961T3 (da) 2002-05-27
EP1001024A2 (fr) 2000-05-17
CZ223793A3 (en) 1994-08-17
WO1992018149A1 (fr) 1992-10-29
HUT66051A (en) 1994-09-28
HU9303012D0 (en) 1994-03-28
DE69232496D1 (de) 2002-04-25
DE69232496T2 (de) 2002-10-10
EP0589961A1 (fr) 1994-04-06
CA2109100A1 (fr) 1992-10-29
HK1024935A1 (en) 2000-10-27
EP0589961A4 (fr) 1994-11-02
NZ242468A (en) 1994-12-22
EP0589961B1 (fr) 2002-03-20
FI934701A0 (fi) 1993-10-25
AU2014992A (en) 1992-11-17
PT100423A (pt) 1993-08-31
AU676664B2 (en) 1997-03-20
SK116593A3 (en) 1994-11-09
DE69233649D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
NO933819L (no) Analysesystemer for neurotrofinaktivitet
EP0727212A3 (fr) Dérivés de la phénylpyrimidine substitués, utile dans le traitement ou la prévention des maladies du système nerveux central
ATE252368T1 (de) Kosmetische oder pharmazeutische zubereitungen mit vermindertem klebrigkeitsgefühl
MX9204301A (es) Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico.
FI964862L (fi) FLT4-reseptorityrosiinikinaasi ja sen käyttö diagnostiikassa ja terapiassa
DE68928515D1 (de) Ultraschallortung und therapiesystem
DE3771185D1 (de) Optischer detektor zur gleichzeitigen erfassung von herzschlag und toraxbewegung.
BR9706835A (pt) Hidrogel de copolìmero de acrilamida implantável para usos terapêuticos
NO895131D0 (no) Fremgangsmaate for analyse av blodplatesammenhopninger og anordning for utfoerelse av fremgangsmaaten.
ATE218857T1 (de) Verwendung von gabapentin und seine derivate in der behandlung von manie und bipolare störungen
IT1242189B (it) Pigmento azoico modificato e la sua preparazione.
NO305795B1 (no) Substituerte benzensulfonylurinstoffer og -tiourinstoffer, og anvendelse i farmas°ytiske preparater pÕ basis av disse forbindelsene samt legemidler inneholdende forbindelsene
NO900635L (no) Herderblanding, samt anvendelse av den.
FI891898A0 (fi) HIV-1:een liittyvät polypeptidit, diagnostiset systeemit ja analyysimenetelmät
ITRM930002A0 (it) Antibiogramma e corredo diagnostico per la sua realizzazione.
NO170908C (no) Immunokjemisk fremgangsmaate for paavisning og bestemmelse av diagnostisk relevante substanser samt anvendelse av fremgangsmaaten
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
RU1826866C (ru) Ретрактор
EP0612355A4 (fr) Detection de la proteine-kinase humaine p58 et de son adn pour le diagnostic de certains cancers.
FI874643A7 (fi) Terapeuttiset aineet ja niiden käyttö.
NO874320D0 (no) Fremgangsmaate for bestemmelse av funksjonelle nivaaer av protein c i humant plasma.
DE59805440D1 (de) Verwendung von lbp zur sepsistherapie
ATE218343T1 (de) Verwendung von substituierten und nichtsubstituierten n-(pyrrol-1-yl)pyridinaminen als antikonvulsiva
DE59609353D1 (de) Mittel zur subkutanen Verabreichung von Protein C
BR8807463A (pt) Emulsao de hidrocarboneto e o uso da mesma